(Total Views: 222)
Posted On: 04/21/2023 5:12:58 PM
Post# of 112
NetworkNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Registered Direct Offering Expected to Total $1.9M
Aditxt (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, has entered into a definitive agreement. The company announced a registered direct offering totaling $1.9 million; the agreement is with a single healthcare-focused institutional investor and includes the purchase and sale of 1,585,350 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $1.22 per share (or common stock equivalents in lieu thereof). According to the announcement, a concurrent private placement calls for the company to also issue unregistered warrants to purchase up to 3,170,700 shares of common stock with an exercise price of $0.86 per share; those shares will be immediately exercisable for a period of three years following issuance. Gross proceeds from the offering are projected to be approximately $1.9 million, and the company plans to use those proceeds to finance working capital and other general corporate purposes. It is anticipated that the offering will close on or about April 24, 2023.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Aditxt (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, has entered into a definitive agreement. The company announced a registered direct offering totaling $1.9 million; the agreement is with a single healthcare-focused institutional investor and includes the purchase and sale of 1,585,350 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $1.22 per share (or common stock equivalents in lieu thereof). According to the announcement, a concurrent private placement calls for the company to also issue unregistered warrants to purchase up to 3,170,700 shares of common stock with an exercise price of $0.86 per share; those shares will be immediately exercisable for a period of three years following issuance. Gross proceeds from the offering are projected to be approximately $1.9 million, and the company plans to use those proceeds to finance working capital and other general corporate purposes. It is anticipated that the offering will close on or about April 24, 2023.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
